Prevalence and Risk factors of Hospital Readmission for Phototherapy due to Rebound Neonatal Jaundice in Chaiyaphum hospital

Authors

  • Sutatip Watthanaphanalai Department of Pediatrics, Chaiyaphum hospital

Keywords:

rebound neonatal jaundice, phototherapy, prevalence, risk factor

Abstract

Background : Neonatal jaundice is a common causes of hospitalization in neonates.Jaundice in neonate require timely treatment for preventing kernicterus.
Objective : To analyze the prevalence and risk factor for readmission for Phototherapy due to Rebound Neonatal Jaundice in Chaiyaphum hospital.
Method : We conducted a retrospective cohort study of infants with jaundice gestational age(GA) ≥35 weeks and and aged 14 days in Chaiyaphum hospital from 1st June 2019 ถึง 31st May 2020.
Result : There were 338 infants with GA≥35 weeksreceiving phototherapy before hospital discharge, 54 (15.98%) of them were readmitted for phototherapy due to rebound jaundice. Readmitted infants had a mean birth weight and gestational age of 2790 ± 502.32 grams and 37.66 ± 1.37 weeks, respectively. Multivariable logistic regression demonstrated that birth weight ≥ 2500 grams decreased risk ofrebound neonatal jaundice requiring phototherapy (OR 0.29, 95%CI: 0.12-0.72, p-value 0.005) while a weight loss of ≥ 5% ( the difference between birth weight and weight at the last day of the first phototherapy ) increases the risk
(OR 1.98, 95% CI:1.10-3.57, p-value 0.023)
Conclusion : The prevalence of readmission for phototherapy due to rebound jaundice in Chaiyaphum Hospital was estimated at 1 out of 6 jaundice infants with GA ≥ 35 weeks. Low birth weight and losing weight ≥ 5% from birth weight on hospital discharge day were the significant risk factors of readmission for phototherapy.

Downloads

Download data is not yet available.

References

Kevin Ives N. Neonatal jaundice In: Janet M. Rennie editer. Rennie&Roberton’s Textbook o f Neonatology. British. ELSEVIER.2012:672-692.

American Academy of Pediatrics, Clinical practice guideline subcommittee on hyperbilirubinemia. Management of hyperbilirubinemia in newborn infant 35 or more week of gestation. Pediatrics 2004;114:297-361.

Management of hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics . 2004; July: 114(2)297-316. www.aappublications.org/ news สืบค้นเมื่อ 3 ธันวาคม 2020.

Maisels M.J, Kring E.A. Length of stay jaundice and hospital readmission.Pediatrics.

;101: 995-8.

Lee K, Perlaman M, Ballantyne M, et al. Association between duration of neonatal hospital stay and readmission rate. J Pediatr. 1995; 127: 758-66.

Soskolne E.L , Schumacher R, Fyock C, et al. The effect of early discharge and other factors on readmission rates of newborns.

Arch Pediatric Adolesc Med. 1996;150:373-9.

Grupp-Phelan J, Taylor J, Liu L, Davis R. Early newborn hospital discharge and readmission for mild and severe jaundice. Arch Pediatr Adolesc Med. 1999;153:1283-8.

Bansal A, Jain S, Parmar Veena R ,et al .Bilirubin Rebound after intensive phototherapy for neonatal jaundice.Indian pediatrics. 2010 July; 47(17) :607-609.

Soni R, Kaushik S, Kaushik R, et al. Post phototherapy bilirubin rebound: incidence and risk factors. Int J Res in Med Sci.2017 Sep;5(9):4112-4116.

Kaplan M, Kaplan E, Hammerman C, et al. Post-phototherapy neonatal bilirubin rebound: potential cause of significant hyperbilirubinaemia. Arch Dis Child. 2006;91:31-34.

AI-Maaroof Z, Abbas W, Shatti A. Rebound increase in Bilirubin level with itsrisk factors after treatment by Intensive phototherapy for

neonatal Hyperbilirubinemia. Indian Journal of Public Health Research & development, 2019 February; 10(02): 646-652.

Chang P, Kuzniewicz M, McCulloch C, et al. A clinical prediction rule for rebound hyperbilirubinemia following inpatient phototherapy. Pediatrics. 2017 March;139(3):e20162896. เข้าถึง https://pediatrics.aappublications.org/content/139/3/e20162896

โครานาม. commonproblemsintheNursery. In สันติ ปุณณะหิตานนท์ บรรณาธิการ. Practical Points and updates in neonatal care. 2562:73-83.

กาญจนพัฒนกุล ว. ภาวะเหลืองในทารกแรกเกิด(neonatal jaundice).ใน: วิบูลย์ กาญจนพัฒนกุล, ศรีศุภลักษณ์ สิงคาลวณิช, และคณะ บรรณาธิการ. ตำ รากุมารเวชศาสตร์ มหาวิทยาลัยรังสิต. 2558:377-385.

Valinjkar S, Sutay N, Sharma B. Rebound Hyperbilirubinemia in neonates after phototherapy and factor affecting It. JMSCR 2017 March; 05(03):19003-19014.

สุุขยานุดิษฐ น. ความชุุกและปัจจัยเสี่่ยงของการรักษาด้้วยการส่่องไฟซ้ำในทารกแรกเกิดที่มีภาวะตัวเหลืองในโรงพยาบาลท่าตููม จังหวัดสุรินทร์.สำำนักงานป้องกันควบคุมโรคที่ 6 จังหวัดขอนแก่น ตุลาคม2555-มีนาคม2556;20(1):19-30

BlumovichA, Mangel L,Yochpaz S, Mandel D, Marom R. Risk factors for readmission for phototherapy due to jaundice in healthy

newborns: a retrospective, observational study. BMC Pediatr. 2020, 26;20:248

ผาตากแดด ส. ปัจจัยเสี่ยงของ การกลับมารักษาซ้ำในทารกแรกเกิดตัวเหลือง ในโรงพยาบาลสุุวรรณภููมิ จังหวัดร้อยเอ็ด . ร้อยเอ็ดเวชสาร.2562;6(1):1-8.

Elhawary I, Ghany A, Aboelhamed W, et al. Incidence and risk factors of post-phototherapy neonatal rebound hyperbilirubinemia. World Journal of pediatrics.2018; 14:350-356.

Burgos AE, Schmitt SK, Stevenson DK, Phibbs CS. Readdmission for neonatal jaundice in california, 1991-2000: trends and

implications. Pediatrics. 2008 Apr; 121(4):e864-9

Downloads

Published

2023-03-31

How to Cite

Watthanaphanalai, S. . (2023). Prevalence and Risk factors of Hospital Readmission for Phototherapy due to Rebound Neonatal Jaundice in Chaiyaphum hospital. Thai Journal of Pediatrics, 62(1), 9–16. retrieved from https://he04.tci-thaijo.org/index.php/TJP/article/view/1050

Issue

Section

Original Articles